SCHEMBL5879324

SCHEMBL5879324

COCCCn1c(=O)c2c3c(=O)n(C)c(=O)c3c3[nH]c4ccccc4c3c2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
GLA P06280 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2C9 P11712 1/20 0.43
CHEK1 O14757 1/20 0.43
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
UTS2R Q9UKP6 1/20 0.41
GAA P10253 2/20 0.41
PLK1 P53350 1/20 0.41
ADRB2 P07550 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5879183 0.85 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4ECYP1A2CHEK1
SCHEMBL5879141 0.83 CHEK1 (0.59) ALDH1A1GLAHSD17B10KDM4ECHEK1
SCHEMBL6201693 0.79 MPO (0.58) ALDH1A1HSD17B10KDM4ECYP1A2CHEK1
SCHEMBL5879203 0.79 MPO (0.58) ALDH1A1HSD17B10KDM4ECYP1A2CHEK1
SCHEMBL5879158 0.78 CHEK1 (0.71) ALDH1A1GLAHSD17B10KDM4ECHEK1
Hydrochloric Acid SCHEMBL5879263 0.78 MPO (0.57) ALDH1A1HSD17B10KDM4ECYP1A2CHEK1
Hydrochloric Acid SCHEMBL5879295 0.78 MPO (0.57) ALDH1A1HSD17B10KDM4ECYP1A2CHEK1
SCHEMBL5879140 0.77 CHEK1 (0.51) ALDH1A1GLAHSD17B10KDM4ECHEK1
SCHEMBL5879155 0.77 CHEK1 (0.51) ALDH1A1HSD17B10KDM4ECHEK1HPGD
SCHEMBL5879196 0.76 CHEK1 (0.50) ALDH1A1HSD17B10KDM4ECHEK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151108-B2 Anticarcinogenic, antiproliferative, and antitumor agents LES LABORATORIES SERVIER (FR) 2006-12-19 US disclosed
EP-1411057-B1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-04-27 EP disclosed
US-20040077672-A1 Anticarcinogenic, antiproliferative, and antitumor agents LES LABORATOIRES SERVIER (FR) 2004-04-22 US disclosed
EP-1411057-A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2004-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077672-A1 Anticarcinogenic, antiproliferative, and antitumor agents XDH, TOP2A, TOP1 ALDH1A1 286/4885GLA 1404/4885HSD17B10 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.